Contact

New Brochure: JPT for Immunotherapy

During the last decade many of you gave us ideas, suggestions and critiques to advance our immunotherapy technologies and products. The result is a comprehensive peptide-based product and service portfolio for  both cellular and humoral immunity.

Our newly designed Immunology Brochure contains new products, services & features, it encourages you to get in touch with our technical support team to discuss your specific peptide needs ranging from neo-epitope qualification and immune monitoring to peptide-based therapies.

Please find recent additions among the following product lines:

Below are examples of recent papers that use our products:
A Single Exercise Bout Enhances the Manufacture of  Viral-Specific T-cells from Healthy Donors: Implications for Allogeneic Adoptive Transfer Immunotherapy
G. Spielmann, C.M. Bollard, H. Kunz et al., Sci Rep (2016) - PMID: 27181409
Deletion of A44L, A46R and C12L Vaccinia Virus Genes from the MVA Genome Improved the Vector Immunogenicity by Modifying the Innate Immune Response Generating Enhanced and Optimized Specific T-Cell Responses

María Pía Holgado, Juliana Falivene, Cynthia Maeto et al., Viruses (2016) -  PMID: 27223301 
Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant Recipients
David Navarro, Paula Amat, Rafael de la Cámara  et al., Oxford Jounals (2016)
A Phase I Study of Recombinant (r) Vaccinia-CEA (6D)-TRICOM and rFowlpox-CEA (6D)-TRICOM Vaccines with GM-CSF and IFN-α-2b in Patients with CEA-expressing carcinomas
Duggan MC, Jochems C, Donahue RN et al., Immunother. (2016) - PMID: 27581603
Human Parainfluenza Virus-3 can be Targeted by Rapidly Ex Vivo Expanded T Lymphocytes

McLaughlin LP, Lang H, Williams E et al.,  Cytotherapy (2016) - PMID: 27692559

Find more publications here!

Happy reading and please contact us with your comments and questions!

Stay in touch and be the first to receive the latest news!